Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
about
The Role of Galectin-3 in the KidneysState of the Art: Newer biomarkers in heart failureThe systemic nature of CKD.Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model.Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive TreatmentLeft ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure.Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure.Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D StudiesGalectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal DamageGalectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve.Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure.Serum Galectin and Renal Dysfunction in ST-Segment Elevation Myocardial Infarction.Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart FailureGalectin 3 complements BNP in risk stratification in acute heart failure.Elevated galectin-3 precedes the development of CKDIncorporating common biomarkers into the clinical management of heart failureSerial galectin-3 and future cardiovascular disease in the general population.Novel biomarkers in chronic heart failure.Clinical use of novel biomarkers in heart failure: towards personalized medicine.The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure.Galectin-3: a modifiable risk factor in heart failure.Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing.Novel renal biomarkers to assess cardiorenal syndromeLong-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes.Cardiovascular biomarkers and sex: the case for women.Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis.Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.ST2 and Galectin-3: Ready for Prime Time?Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.
P2860
Q26752754-89B6474D-0276-4D1F-8E5C-0A59A984EE6CQ27027899-3E5087BA-2941-4291-8E7F-EE5A77C4FD69Q30234695-D112FB86-3FA4-4542-95C8-85C102650055Q33606538-6FE98DAB-FDB2-4B84-B1E8-3FC95CE74C8BQ33754895-C8ED525E-075C-4799-B31C-6D2DB74F0098Q33791650-FDC98D83-FA07-4EBF-AA7D-B8B1BFE05B0DQ33897327-DA959F6D-263E-4C79-9AC7-6397E751C800Q33912126-0A30557F-12F0-4BD6-B402-D1A7313E5BCCQ34102031-D9112DC7-80FB-4350-A0D5-260639650043Q35026202-E190F24D-2C3D-4FCC-ADE2-57BDF236AE59Q35206146-D586E64D-6270-4B01-B968-24E8AE39C55AQ35286926-FEDB4FFE-AEC9-4F51-AAA7-89B86585A142Q35680958-4690D8EE-5701-4B4D-B029-A3055A4DAF78Q36003071-1F08284A-48B6-41DF-954D-DAF12206C849Q36035702-1EBC29A8-1FA8-4D16-8255-25AA5FE37968Q36187612-F34D0365-D978-4F8E-84D0-08FE27F9DCA2Q36244494-AA01BA67-2A25-4291-85BE-3A2A69DE1E8CQ36439679-9C6BDBB2-2452-40C6-A7A1-650840323D64Q36522700-9715FBE3-5C46-4F8B-A872-EF5431C7F682Q36627699-A498B627-0E82-46C3-9F4A-B0B94E372C1FQ36757833-A41C2F14-07A3-44FA-A7AC-F966FCDFEC7FQ36917873-43583B4F-BA80-473F-899E-F0EC1B51DB54Q37119904-C44E7E0F-AAFF-45FA-B29A-1DE85A929C1BQ37347009-A589AC8B-5A45-4D30-9B58-39E57DD2C87BQ37580709-5CCA72F2-D565-42C5-A969-289E0C1BD0E3Q37997237-A500199F-3340-449E-A983-65B67835EF57Q38109588-4959CA9B-6659-4039-ADD6-B0E0E995BC99Q38154222-B7552BE7-DF1C-4268-9A5F-268709578241Q38194209-A5C020F1-065E-46D6-9C53-B87ABEE7CC2FQ38208784-D4CC20BE-5BB0-410F-BBD3-8CB8BC6CDDFCQ38225729-DF1596E5-1635-4CC0-8C93-AD1A420B198BQ38252731-251FD9CE-5156-4B1D-B76D-3895FAD0C37CQ38426618-570B24E2-1D14-4C0A-9B7F-49CC0EA312ACQ38543356-62B43677-3592-41DD-9B73-FA21F8566AE7Q38596113-B3740BDA-D3BA-4F84-91C0-51A659C867FDQ38727409-18720C7E-33B5-4B3E-A025-3E71C0714C3FQ38756838-A9DEDE1B-926A-4ACC-B85E-C08FD8FCB59FQ38816590-3AE4A3FC-FBD7-4ADA-AE19-FEC51C92CCDAQ38977493-E4EB3C29-DC7D-4008-AC0B-58B75A79D903Q39303610-4DAEEAD5-0D26-421E-B8B8-CA8326E17F92
P2860
Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Usefulness of plasma galectin- ...... al insufficiency and survival.
@ast
Usefulness of plasma galectin- ...... al insufficiency and survival.
@en
type
label
Usefulness of plasma galectin- ...... al insufficiency and survival.
@ast
Usefulness of plasma galectin- ...... al insufficiency and survival.
@en
prefLabel
Usefulness of plasma galectin- ...... al insufficiency and survival.
@ast
Usefulness of plasma galectin- ...... al insufficiency and survival.
@en
P2093
P2860
P1476
Usefulness of plasma galectin- ...... nal insufficiency and survival
@en
P2093
Allan L Klein
Allen G Borowski
James D Thomas
Kevin Shrestha
W H Wilson Tang
Zhili Shao
P2860
P304
P356
10.1016/J.AMJCARD.2011.03.056
P407
P577
2011-05-19T00:00:00Z